U.S. Point-of-Care Diagnostics Market Set to Reach $13.16 Billion by 2030

Meticulous Research® Unveils Comprehensive Insights in Latest Report on U.S. Point-of-Care Diagnostics Market
Meticulous Research®, a prominent global market research firm, has released an in-depth research report titled, "U.S. Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker), Platform (LFA, Molecular), Sample (Blood, Urine), End User - Forecast to 2030."

Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730

In this latest publication from Meticulous Research®, the U.S. point-of-care diagnostics market is projected to showcase a Compound Annual Growth Rate (CAGR) of 4.3% from 2023, reaching an impressive valuation of $13.16 billion by the year 2030. The market's growth trajectory is attributed to groundbreaking advancements in Point-of-Care (POC) tests, increasing commercialization of Clinical Laboratory Improvement Amendments (CLIA)-waived POC tests, augmented research and development funding, heightened awareness concerning early disease diagnosis, and a surge in chronic diseases prevalent among the aging population. However, challenges such as stringent regulatory policies and pricing pressures due to reimbursement fluctuations pose impediments to market growth.

Market Dynamics

The report underscores the pivotal role of innovation in POC tests, emphasizing the growing commercialization of CLIA-waived POC tests. Furthermore, the surge in funding for research and development, the rise in awareness regarding early disease diagnosis, and the increasing prevalence of chronic diseases are key drivers fueling the U.S. point-of-care diagnostics market. Despite these positive factors, the market faces challenges in the form of stringent regulatory policies and pricing pressures resulting from reimbursement fluctuations.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/us-point-of-care-diagnostics-market-5730

Amidst these challenges, the U.S. point-of-care diagnostics market is poised for significant growth opportunities, driven by escalating investments in healthcare infrastructure and a growing preference among healthcare professionals for POC tests over traditional lab tests.

Key Players Shaping the Market

The report highlights key players influencing the U.S. point-of-care diagnostics market, including Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), QuidelOrtho Corporation (U.S.), Sekisui Diagnostics, LLC. (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), and Nova Biomedical (U.S.).

Future Outlook

The U.S. point-of-care diagnostics market is meticulously analyzed in the report based on offering, platform, application, sample type, and end user. The consumables segment is anticipated to hold the largest share in 2023, driven by the recurrent use of consumables in disease detection, increased product approvals, and technological advancements in ELISpot assay kits.

Have Any Query ? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5730

Molecular diagnostics is projected to register the highest CAGR, emphasizing its high sensitivity, accuracy, and wide applications across various fields. In 2023, blood glucose monitoring is expected to dominate the market among applications, with a significant market share attributed to the rising prevalence of diabetes and increased consumer awareness.

The blood sample type segment is forecasted to exhibit the highest CAGR, owing to the availability of a wide variety of tests using blood samples and the increasing prevalence of chronic diseases. In terms of end-users, hospitals are anticipated to account for the largest share in 2023, fueled by various tests performed to diagnose medical conditions, coupled with the increasing healthcare expenditure.
For further insights and a detailed analysis, please refer to the complete "U.S. Point-of-Care Diagnostics Market by Meticulous Research® - Forecast to 2030" report.
Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730

Related Research:
1. Point of care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030 https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871

2. Asia-Pacific Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Forecast to 2030 https://www.meticulousresearch.com/product/asia-pacific-point-of-care-diagnostics-market-5671

3. Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis) Platform (LFA, Molecular) Sample, and End User - Forecast to 2030 https://www.meticulousresearch.com/product/europe-point-of-care-diagnostics-market-5650

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.